The Hyperfunction Theory of Aging: Three Common Misconceptions

Overview

Journal Oncoscience

Specialty Oncology

Date 2021 Sep 22

PMID 34549076

Citations 15

Authors

Mikhail V Blagosklonny

Affiliations

Soon will be listed here.

Citing Articles

Mikhail 'Misha' Blagosklonny's enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin.

Barzilai D Aging (Albany NY). 2025; 17(1):1-15.

PMID: 39808121 PMC: 11810056. DOI: 10.18632/aging.206189.

Genetic, Environmental, and Stochastic Components of Lifespan Variability: The Paradigm.

Bylino O, Ogienko A, Batin M, Georgiev P, Omelina E Int J Mol Sci. 2024; 25(8).

PMID: 38674068 PMC: 11050664. DOI: 10.3390/ijms25084482.

LPD-3 as a megaprotein brake for aging and insulin-mTOR signaling in C. elegans.

Pandey T, Wang B, Wang C, Zu J, Deng H, Shen K Cell Rep. 2024; 43(3):113899.

PMID: 38446666 PMC: 11019932. DOI: 10.1016/j.celrep.2024.113899.

Meta-analysis shows no consistent evidence for senescence in ejaculate traits across animals.

Sanghvi K, Vega-Trejo R, Nakagawa S, Gascoigne S, Johnson S, Salguero-Gomez R Nat Commun. 2024; 15(1):558.

PMID: 38228708 PMC: 10791739. DOI: 10.1038/s41467-024-44768-4.

My battle with cancer. Part 1.

Blagosklonny M Oncoscience. 2024; 11:1-14.

PMID: 38188499 PMC: 10765422. DOI: 10.18632/oncoscience.593.

References

Johnson S, Yanos M, Kayser E, Quintana A, Sangesland M, Castanza A . mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science. 2013; 342(6165):1524-8. PMC: 4055856. DOI: 10.1126/science.1244360. View

Blagosklonny M . Rapamycin, proliferation and geroconversion to senescence. Cell Cycle. 2018; 17(24):2655-2665. PMC: 6343718. DOI: 10.1080/15384101.2018.1554781. View

Blagosklonny M . Hormesis does not make sense except in the light of TOR-driven aging. Aging (Albany NY). 2011; 3(11):1051-62. PMC: 3249451. DOI: 10.18632/aging.100411. View

Demidenko Z, Blagosklonny M . Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential. Aging (Albany NY). 2010; 1(12):1008-16. PMC: 2815749. DOI: 10.18632/aging.100115. View

Wang H, Zhang Z, Gems D . Monsters in the uterus: teratoma-like tumors in senescent result from a parthenogenetic quasi-program. Aging (Albany NY). 2018; 10(6):1188-1189. PMC: 6046241. DOI: 10.18632/aging.101486. View

Velarde M, Demaria M, Campisi J . Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip Top Gerontol. 2013; 38:17-27. PMC: 4167737. DOI: 10.1159/000343572. View

Agronin M . From Cicero to Cohen: developmental theories of aging, from antiquity to the present. Gerontologist. 2013; 54(1):30-9. DOI: 10.1093/geront/gnt032. View

Swindell W . Rapamycin in mice. Aging (Albany NY). 2017; 9(9):1941-1942. PMC: 5636660. DOI: 10.18632/aging.101289. View

Blagosklonny M . Cell senescence and hypermitogenic arrest. EMBO Rep. 2003; 4(4):358-62. PMC: 1319162. DOI: 10.1038/sj.embor.embor806. View

10.

Powers 3rd R, Kaeberlein M, Caldwell S, Kennedy B, Fields S . Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006; 20(2):174-84. PMC: 1356109. DOI: 10.1101/gad.1381406. View

11.

Walker R . Developmental theory of aging revisited: focus on causal and mechanistic links between development and senescence. Rejuvenation Res. 2011; 14(4):429-36. DOI: 10.1089/rej.2011.1162. View

12.

Kaeberlein M, Powers 3rd R, Steffen K, Westman E, Hu D, Dang N . Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005; 310(5751):1193-6. DOI: 10.1126/science.1115535. View

13.

DILMAN V . Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease. Lancet. 1971; 1(7711):1211-9. DOI: 10.1016/s0140-6736(71)91721-1. View

14.

Blagosklonny M . Answering the ultimate question "what is the proximal cause of aging?". Aging (Albany NY). 2013; 4(12):861-77. PMC: 3615154. DOI: 10.18632/aging.100525. View

15.

DILMAN V . Transformation of the development program in the mechanism of age pathology. An elevational model of age pathology and natural death in man. Hum Physiol. 1978; 4(4):465-78. View

16.

Blagosklonny M . Prospective treatment of age-related diseases by slowing down aging. Am J Pathol. 2012; 181(4):1142-6. DOI: 10.1016/j.ajpath.2012.06.024. View

17.

Blagosklonny M . DNA- and telomere-damage does not limit lifespan: evidence from rapamycin. Aging (Albany NY). 2021; 13(3):3167-3175. PMC: 7906135. DOI: 10.18632/aging.202674. View

18.

Ezcurra M, Benedetto A, Sornda T, Gilliat A, Au C, Zhang Q . C. elegans Eats Its Own Intestine to Make Yolk Leading to Multiple Senescent Pathologies. Curr Biol. 2018; 28(16):2544-2556.e5. PMC: 6108400. DOI: 10.1016/j.cub.2018.06.035. View

19.

Blagosklonny M . TOR-driven aging: speeding car without brakes. Cell Cycle. 2009; 8(24):4055-9. DOI: 10.4161/cc.8.24.10310. View

20.

Demidenko Z, Blagosklonny M . Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle. 2008; 7(21):3355-61. DOI: 10.4161/cc.7.21.6919. View